BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 6799985)

  • 1. Antianginal drugs for stable angina pectoris.
    Aronow WS
    Ration Drug Ther; 1982 Jan; 16(1):1-7. PubMed ID: 6799985
    [No Abstract]   [Full Text] [Related]  

  • 2. [Double-blind clinical trial of a new coronary-active drug, MD 6753].
    Dalla Volta S
    Minerva Cardioangiol; 1974 Oct; 22(10):683-90. PubMed ID: 4215049
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinico-ergometric evaluation of timolol maleate in stable angina: double-blind, randomized and crossed study].
    Batlouni M; Armaganijan D; Campos CR
    Arq Bras Cardiol; 1986 Feb; 46(2):143-6. PubMed ID: 3548661
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in intracardiac hemodynamics and the tolerance for physical loading as affected by Nitrong in persons suffering from ischemic heart disease].
    Gasilin VS; Shevchenko OP; Maksumov EIu; Lupanov VP
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):59-64. PubMed ID: 6789850
    [No Abstract]   [Full Text] [Related]  

  • 5. Diuretic therapy and angina pectoris.
    Parker JD
    Cardiologia; 1998 Mar; 43(3):261-5. PubMed ID: 9611853
    [No Abstract]   [Full Text] [Related]  

  • 6. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
    Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
    J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
    Makolkin VI; Vakhliaev VD
    Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A kinetodardiographic approach to the evaluation of antianginal drugs.
    Slany J; Mösslacher H; Kronik G
    Bibl Cardiol; 1976; (35):191-6. PubMed ID: 825098
    [No Abstract]   [Full Text] [Related]  

  • 9. Antianginal drugs.
    Kaverina NV; Chumburidze VB
    Pharmacol Ther; 1979; 4(1):109-53. PubMed ID: 88742
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of ethyl cinepazate maleate on the exercise tolerance test in patients with angina pectoris].
    Cherchi A; Fonzo R; Mercuro G; Lai C
    Boll Soc Ital Cardiol; 1978; 23(1):265-80. PubMed ID: 113021
    [No Abstract]   [Full Text] [Related]  

  • 11. Coronary heart disease. Hemodynamic response to exercise before and after nitroglycerin.
    Di Giorgi S; West RO; Parker JO
    Mal Cardiovasc; 1968; 9(1):29-50. PubMed ID: 4981691
    [No Abstract]   [Full Text] [Related]  

  • 12. Tolerance to the hemodynamic and antianginal effects of the organic nitrates.
    Parker JO
    Z Kardiol; 1985; 74 Suppl 1():45-9. PubMed ID: 3922142
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the response of nitroglycerin oral spray compared with sublingual tablets for angina pectoris patients with dry mouth. A multicenter trial.
    Sato H; Koretsune Y; Taniguchi T; Fukui S; Shimazu T; Sugii M; Matsuyama T; Karita M; Hori M
    Arzneimittelforschung; 1997 Feb; 47(2):128-31. PubMed ID: 9079231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative efficacy, safety, cardio-hemodynamic effects of isosorbide dinitrate (ID) aerosol and sublingual tablets of nitroglycerin].
    Ol'binskaia LI; Sizova ZhM; Ushakova AV
    Ter Arkh; 1998; 70(5):69-72. PubMed ID: 9644750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nitroglycerin and slow-acting drugs in angina pectoris].
    Oye I
    Tidsskr Nor Laegeforen; 1972 Feb; 92(5):353-5. PubMed ID: 4622663
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of the effect of nitroglycerine and pentaerithritol compositum on exercise time restricted by anginal pain or objective parameters of ischaemia in patients with stable angina].
    Siński M; Lewandowski J; Abramczyk P; Nowosad H; Grzelak-Szafrańiska H
    Pol Arch Med Wewn; 2005 Aug; 114(2):755-60. PubMed ID: 16808313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical usefulness of high-dose oral nitroglycerin in patients with stable angina pectoris].
    Kośmicki MA; Skorykow-Sapińska A; Sadowski Z
    Wiad Lek; 2003; 56(7-8):313-8. PubMed ID: 14969156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiology of Angina and Its Alleviation With Nitroglycerin: Insights From Invasive Catheter Laboratory Measurements During Exercise.
    Asrress KN; Williams R; Lockie T; Khawaja MZ; De Silva K; Lumley M; Patterson T; Arri S; Ihsan S; Ellis H; Guilcher A; Clapp B; Chowienczyk PJ; Plein S; Perera D; Marber MS; Redwood SR
    Circulation; 2017 Jul; 136(1):24-34. PubMed ID: 28468975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of a static exercise test for evaluating anti-angina effects of drugs in patients with ischemic heart disease at a polyclinic].
    Gel'fgat EB; Muradova SA; Iagizarova NM; Abdullaeva IA
    Kardiologiia; 1988 Oct; 28(10):47-51. PubMed ID: 3147339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of perhexiline maleate in patients with angina pectoris unrelieved by other antianginal agent.
    Alcocer L; Aspe J; Arce-Gomez E
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):349-57. PubMed ID: 4198295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.